Building consents in New Zealand rose to near decade high during the month of September, snapping two months of continuous decline as a spurt in Wellington apartment permits offset a decline in new house permits.
New Zealand’s seasonally adjusted dwelling consents increased 0.2 percent to 2,618 in September, turning around a 1.5 percent decline in August. Permits for new houses fell 2.5 percent to 1,813, having gained 4.1 percent a month earlier, data released by, Statistics New Zealand showed Monday.
On an annual basis, residential consents rose 14 percent to 29,935, including a 15 percent gain in new housing permits to 21,299, data showed. However, excluding the volatile apartment sector, consents for new houses fell 2.5 percent.
Further, the value of non-residential permits fell 18 percent to USD509 million in September from the same month a year earlier, smaller than the 42 percent decline in floor area to 202,000 square metres. On an annual basis, the value of non-residential work permits rose 6.8 percent to USD6.05 billion, while the floor area shrank 16 percent to 2.83 million square metres.
"All nine North Island regions consented more new dwellings in the latest year ended September than in the previous one," said Neil Kelly, Senior Manager, Business Indicators, Statistics New Zealand.


Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
FxWirePro: Daily Commodity Tracker - 21st March, 2022
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



